title: TLR4 agonists as vaccine adjuvants: a chemist's perspective.
authors.forename: David A
authors.initials: DA
authors.lastname: Johnson
mesh_terms: D016915:AIDS Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology; D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology*; D019496:Cancer Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology; D006801:Humans; D017780:Malaria Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology; D051197:Toll-Like Receptor 4 / Q000819:agonists*; D014611:Vaccination / Q000009:adverse effects / Q000379:methods*
chemical_list: D016915:AIDS Vaccines; D000276:Adjuvants, Immunologic; D019496:Cancer Vaccines; D017780:Malaria Vaccines; D051197:Toll-Like Receptor 4